Abstract
Objective
To evaluate effect of addition of ipratropium to salbutamol delivered by metered dose inhaler and spacer in the beginning of treatment of mild to moderate exacerbation of asthma.
Methods
Children between 5 to 15 years of age with mild to moderate exacerbation of asthma were randomized to receive either a combination of ipratropium bromide and salbutamol or salbutamol alone administered by metered dose inhaler and spacer. The effects on clinical asthma score and spirometric parameters were compared.
Results
A total of 60 children were randomized in the study. The baseline characteristics of two groups were comparable. Children getting combination of salbutamol and ipratropium showed significantly greater improvement in percent-predicted PEFR and FEF25–75% than children receiving salbutamol alone.
Conclusion
There was beneficial effect of addition of ipratropium to salbutamol administered by MDI with spacer at the beginning of therapy for mild to moderate acute exacerbation of asthma in children.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Garrett JE, Town GI, Rodwell P, Kelly AM. Ipratropium bromide in the treatment of acute asthma.J Allergy Clin Immunol 1997; 100: 165–170.
Lin RY, Pesola GR, Bakalchuk L,et al. Superiority of ipratropium plus albuterol over albuterol alone in the emergency department management of adult asthma—A randomised clinical trial.Ann Emergency Med 1998; 31: 208–213.
Rodrigo GJ, Rodrigo C. First time therapy for adult patients with acute asthma receiving multiple dose protocol of ipratropium bromide plus albuterol in emergency department.Am J Respir Crit Care Med 2000; 161: 1863–1868.
Schuh S, Johnson DW, Callahan S,et al. Efficacy of frequent nebulised ipratropium bromide added to frequent high dose Albuterol therapy in severe childhood asthma.J Pediatr 1995; 126: 639–45.
Qureshi F, Zaritsky A, Lakkis H. Efficacy of nebulised ipratropium in severely asthmatic children.Ann Emergency Med 1997; 29: 205–210.
Qureshi F, Pestian J, Davis P,et al. Effect of neubulised ipratropium on hospitalisation rates on children with asthma.NEJM 1998; 339: 1030–1035.
Ratageri V, Kabra SK, Dwivedi SN, Seth V. Factors associated with severe asthma.Indian Pediatrics 2000; 37: 1037–1082.
Corne JM, Holgate ST. Mechanism of virus induced exacerbation of asthma.Thorax 1997; 52: 380–389.
Cales CJ, Rowe BH. Holding chambers versus nebulisers for beta-agonist treatment of acute asthma.Cochrane Database Syst 2002.
Guidelines for the Diagnosis and Management of Asthma. NIH Publication No. 97-4051, July 1997.
Bentur L, Canny GJ, Shields MD,et al. Controlled trial of nebulised albuterol in children younger than two years of age with acute asthma.Pediatrics 1992; 89: 133–137.
Ream RS, Loftis LL, Albers GM,et al. Efficacy of intravenous theophylline in children with severe status asthmaticus.Chest 2001; 119: 1480–1488.
Bierman CW, Pearlman DS. Asthma- average (50%) pulmonary values in children. In Kendig EL, Chernick V, Eds.Disorders of the Respiratory Tract in Children. 4th Edition, Philadelphia, WB Saunders and Company. 1983; pp 521.
Consensus guideline on management of childhood asthma in India.Indian Pediatr 1999; 36: 157–165.
Beck R, Robertson C, Sebaldt MG,et al. Combined salbutamol and ipratropium bromide by inhalation in the treatment of severe acute asthma.J Pediatr 1985; 107: 605–608.
Storr J, Lenney W. Nebulised ipratropium and salbutamol in asthma.Arch Dis Child 1986; 61: 602–603.
Goggins N, Macarthurs C, Parkin PC. Randomised trial of the addition of ipratropium bromide to albuterol and corticosteroid therapy in children hospitalised because of an acute asthma exacerbation.Arch Pediatr Adolesc Med 2001; 155: 1329–1334.
Rayner RJ, Cartlidge PHT, Upton CJ. Salbutamol and ipratropium in acute asthma.Arch Dis Child 1987; 62: 840–841.
Zorc JJ, Pusic MV, Ogborn CJ,et al. Ipratropium bromide added to asthma children in pediatric emergency department.Pediatrics 1999; 103: 748–752.
Plotnick LH, Ducherme FM. Should inhaled anti cholinergics be added to beta 2agonist for treating acute childhood and adolescent asthma.-A systemic review.BMJ 1998; 317: 971–977.
Jacoby DB. Virus-induced asthma attacks.J Aerosol Med 2004; 17: 169–173.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Chakraborti, A., Lodha, R., Pandey, R.M. et al. Randomized controlled trial of ipratropium bromide and salbutamol versus salbutamol alone in children with acute exacerbation of asthma. Indian J Pediatr 73, 979–983 (2006). https://doi.org/10.1007/BF02758300
Issue Date:
DOI: https://doi.org/10.1007/BF02758300